Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Triple Detector Array

By Drug Discovery Trends Editor | May 13, 2010

viscotekMalvern Instruments has extended the applications for its Viscotek Triple Detector Array (TDA), the multi-detector platform for gel permeation/size exclusion chromatography (GPC/SEC), through the inclusion of a new viscometer in the setup. The TDA maximises the productivity of GPC/SEC analysis by simultaneously measuring absolute molecular weight, molecular size and intrinsic viscosity. The new viscometer combines unrivalled sensitivity with an innovative 316 stainless steel transducer construction that offers excellent chemical resistance. It therefore provides the most precise intrinsic viscosity and structural information for an expanded range of biomolecules, natural and synthetic polymers.

The unique viscometer design uses digital inert transducer technology to give a faster, more sensitive response to viscosity changes than traditional transducers. Its 316 stainless steel construction means that there are now few limitations, in terms of salt content or pH, on the chromatographic conditions that can be used. This is a significant benefit for protein analysis. The use of inert capillaries in the measuring flow path is also advantageous for many biomolecule applications.

The TDA lies at the heart of the Viscotek TDAmax: a complete, advanced GPC/SEC system suitable for all macromolecular applications. However, each element of the TDA can be purchased alone or in combination, offering exceptional flexibility to those with existing GPC/SEC systems. UV and/or PDA detectors are also available to further augment detection capabilities. These are especially useful for the analysis of composition for copolymers and/or conjugated proteins.

Date: April 27, 2010
Source: Malvern Instruments 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE